The Drug Coated Balloon Club meeting

The DCB Club 2025

7th & 8th November 2025 - BERLIN, GERMANY

Dedicated to sharing knowledge, improving the safety and efficacy of Drug Coated Balloon use.

“Drug-Coated Balloons in Contemporary PCI – From Science to Practice”

Meeting Objectives

Understand the pathophysiology of CAD based on intravascular imaging and physiology.
Learn why and how DCB technology is reshaping PCI strategy for the future.
Exchange interpretations and implications of recent major clinical trials on DCB.
Communicate current research needs and discuss future investigative requirements.The DCB Club will delve into the multitude of unanswered questions, dive into contentious debates, and track the rapid evolution of evidence in this captivating realm.

‘The DCB Club is not just a meeting of like minded experts…

it's a driving force for positive change in DCB education & treatment’.

Join us in our commitment to promoting best practices, fostering collaboration, and ultimately improving patient outcomes.

Together, we can shape the future of DCB education & treatment.

The DCB Club 2025 – Berlin, Germany
“Drug-Coated Balloons in Contemporary PCI – From Science to Practice”

The Drug-Coated Balloon (DCB) Club returns to Berlin in November 2025, bringing together global experts in interventional cardiology for an immersive two-day programme focused on advancing the science and clinical application of DCB technology in percutaneous coronary intervention (PCI). Designed for experienced operators and opinion leaders, this year’s meeting explores how DCBs are reshaping the future of PCI—from initial lesion assessment to long-term patient outcomes.

Structured around cutting-edge scientific sessions, the agenda dives deep into the pathophysiology of coronary artery disease, the evolution of DCB technologies, and the strategic considerations for their use in various complex lesion subsets including bifurcations, CTOs, high-bleeding-risk patients, and STEMI/NSTEMI scenarios.

Attendees will engage with the latest clinical trial data, explore contemporary imaging and lesion preparation techniques, and discuss drug selection, hybrid strategies, and emerging alternatives like bioresorbable scaffolds. The meeting also emphasizes open dialogue through focused Q&A, breakout sessions with industry, and collaborative consensus-building—culminating in a forward-looking discussion on future research needs and key messages for a DCB consensus paper.

Led by pioneers in the field such as Bruno Scheller, Franz Kleber, Raban Jeger, Victor Jimenez, Simon Eccleshall, Ulf Landmesser, Tuomas Rissanen & Fernando Alfonso, the DCB Club is more than a scientific forum—it’s a collaborative platform driving innovation and best practice in DCB-based PCI.

Meet the Course Directors:

Prof Franz Kleber
Prof Bruno Scheller
Prof Raban Jeger
Prof Victor Jimenez
Prof Simon Eccleshall
Prof Ulf Landmesser
Prof Tuomas Rissanen
Prof Fernando Alfonso

This year’s DCB Club meeting is gratefully sponsored by the following companies:

Cordis is proud to have completed the acquisition of MedAlliance and its novel SELUTION SLR™ Drug-Eluting Balloon (DEB).

The SELUTION SLR™ Drug Eluting Balloon (DEB) is the latest generation of drug-eluting balloon technology designed to Go Beyond Metal and deliver consistent and predictable drug release as best-in-class drug-eluting stents

Cordis is committed to accelerating the development and commercialisation of innovative cardiovascular interventional products around the world.

Visit our website to learn more

We lead global healthcare technology, boldly attacking the most challenging problems. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ people, and our technologies transform the lives of two people every second, every hour, every day. Expect more from us. Medtronic. Engineering the extraordinary.

Interventional Cardiology

From advanced intravascular imaging to lesion preparation and drug-eluting therapies – discover a complete portfolio designed to support informed decisions and optimal patient outcomes.

“Modern PCI means integrating new techniques into a systemic PCI approach that patients understand and physicians can implement” Prof. James Spratt

Our Modern PCI solutions evolve thanks to your input. You inspire us to design a PCI toolkit that equips you with the precision, control, and insights needed to tailor treatment for every coronary lesion.

We are Modern PCI.